HRMY: Harmony Biosciences Holdings, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | New 13G stake | Vanguard Portfolio Management | 5.08% | SEC | |
| 2026-07-28 | 13G amendment | BlackRock, Inc. | 11.30% | SEC |
Institutional ownership (Q2 2026)
328 institutions reported holding $1.80B of Harmony Biosciences Holdings, Inc. on Form 13F (311 the quarter before). 49 opened a new position and 32 sold out. Shares held by institutions: -3%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 7,101,965 | $258.58M |
| FMR LLC | 3,574,115 | $130.13M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,880,489 | $104.88M |
| AMERICAN CENTURY COMPANIES INC | 2,539,512 | $92.46M |
| DIMENSIONAL FUND ADVISORS LP | 2,393,588 | $87.14M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,105,053 | $76.64M |
| STATE STREET CORP | 1,859,322 | $67.70M |
| ARMISTICE CAPITAL, LLC | 1,564,000 | $56.95M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,442,649 | $52.53M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,312,550 | $47.79M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.